These findings were further supported by the analysis of the trends with mAUC, which showed no statistically significant difference between groups (p fT3 = 0.147 and p fT4 = 0.132) (Supplementary Figures S3a and S4a)
Nausea, fatigue, constipation, diarrhea, bloating, and dizziness are among the commonly reported side effects, particularly during the initial phase of treatment or after a dose increase
It's best to start low and adjust gradually, always following label instructions or a healthcare providers advice
Efficacy and safety of insulin-GLP-1 receptor agonists combination in type 2 diabetes mellitus: a systematic review
Anti-inflammatory medications provide temporary relief without addressing underlying tissue damage
Basic Res Cardiol (2016) 111:1